Print Page  Close Window

Press Releases

Keyword Search
 
Current | Archive
DateTitle 
11/29/16OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program
BETHLEHEM, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it will begin fulfilling a contract to supply a foreign government with $18 million of product, primarily to support a nationwide hepatitis C (HCV) testing and treatment program with the goal of eliminating HCV infection across the country by 2020. The contract calls for the purchase of $16 million of Ora... 
Printer Friendly Version
11/29/16Helix Selects DNA Genotek’s Oragene® Collection Device and GenoFIND Fulfillment Services for Genetic Discovery Applications
- Oragene®●Dx saliva collection kits to provide reliable DNA samples for Helix - BETHLEHEM, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that Helix, the personal genomics company, has selected the Oragene®Ÿ●Dx device to provide reliable self-collection of DNA samples to be used in a genetic information discovery service offered by Helix for consumers.  OraSure’s whol... 
Printer Friendly Version
11/21/16OraSure Technologies to Host Analyst Day
BETHLEHEM, Pa., Nov. 21, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in point-of-care diagnostic tests and specimen collection devices, today announced that it will host an Analyst Day meeting on Tuesday, November 29, 2016 in New York City, New York, at the NASDAQ MarketSite at Times Square.  Presentations by OraSure’s senior executive team are scheduled to begin at 10:00 a.m. (Eastern Time) and conclude by 1:00 p.m. (Eastern Time) and will cover various ... 
Printer Friendly Version
11/15/16OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors
BETHLEHEM, Pa., Nov. 15, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Stephen S. Tang, Ph.D., as Chairman of the Company’s Board of Directors (the “Board”), effective November 14, 2016. Dr. Tang has been a Board member since April 2011, has served as Chairman of the Compensation Committee since May 2014 and is also a member of the Nominating and Corporate Governa... 
Printer Friendly Version
11/09/16OraSure Technologies to Present at the 10th Annual Canaccord Genuity Medical Technology & Diagnostics Forum
BETHLEHEM, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 10th Annual Canaccord Genuity Medical Technology & Diagnostics Forum in New York.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 17, 2016, at approximat... 
Printer Friendly Version
11/02/16OraSure Announces 2016 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 02, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and nine months ended September 30, 2016. Financial Highlights Consolidated net revenues for the third quarter of 2016 were $32.3 million, an 8% increase from the third quarter of 2015. Consolidated net revenues for the nine months ended September 30, 2016 ... 
Printer Friendly Version
10/14/16OraSure Technologies Announces 2017 Annual Meeting Date
BETHLEHEM, Pa., Oct. 14, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2017 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 16, 2017.  This will be a completely virtual meeting, conducted as a live webcast.  Further details regarding the meeting will be provided at a later date. About OraSure Technologies OraSure Technologies is a leader in the development, manufacture and distribution of ... 
Printer Friendly Version
10/12/16OraSure Technologies Earnings Conference Call Invitation
2016 Third Quarter Earnings Conference Call Wednesday, November 2, 2016, 5:00 p.m. ET BETHLEHEM, Pa., Oct. 12, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 third quarter financial results, 2016 fourth quarter financial guidance, and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 2, 2016.   November 2, 2016 Schedule 4:00 p.m. ET   2016 third quarter fina... 
Printer Friendly Version
09/06/16OraSure Technologies to Present at the CL King 14th Annual Best Ideas Conference
BETHLEHEM, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the CL King 14th Annual Best Ideas Conference in New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on September 13, 2016, at approximately 10:15 AM Eastern Time (7:1... 
Printer Friendly Version
08/29/16DNA Genotek’s OMNIgene®Ÿ GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome
Human Longevity Inc. Study on OMNIgene®Ÿ GUT Recently Published in Scientific Reports BETHLEHEM, Pa., Aug. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that a study conducted by Human Longevity, Inc. (HLI) and published in the Journal Scientific Reports (Nature Publishing Group) on August 25, 2016 proposes the use of the OMNIgene•GUT microbiome sample collection and stabilization device sold by OraSure’s wholly-owned subsidiary, DNA Genotek Inc., in gl... 
Printer Friendly Version